Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca angles for more competitive position in immuno-oncology
AstraZeneca angles for more competitive position in immuno-oncology
AstraZeneca angles for more competitive position in immuno-oncology
Submitted by
admin
on January 19, 2017 - 11:19am
Source:
BioPharma Dive
News Tags:
AstraZeneca
immuno-oncology
tremelimumab
durvalumab
Headline:
AstraZeneca angles for more competitive position in immuno-oncology
Do Not Allow Advertisers to Use My Personal information
